October 2005 Fellow in the American College of Surgeons
February 2004 American Board of Urology
Part II orals Pass
June 2002 American Board of Urology
Part I Pass
June 1994 National Board of Medical Examiners
Part I Pass
August 1995 National Board of Medical Examiners
Part II Pass
Maryland state medical license: 2002
Pennsylvania state medical license: 1998
1992-1996 M.D., Temple University
School of Medicine
Philadelphia, Pennsylvania
1987-1991 B.S., St. Joseph's University
Biology
Philadelphia, Pennsylvania
2007-Present Chesapeake Urology Research Associates
2002-Present Clinical Urologist
Chesapeake Urology Associates
Baltimore, MD
1998-2002 Urology Residency
Temple University Hospital
Department of Urology
Philadelphia, Pennsylvania
1997-1998 General Surgery Resident
Temple University Hospital
General Surgery Department
Philadelphia, Pennsylvania
1996-1997 General Surgery Intern
Temple University Hospital
General Surgery Department
Philadelphia, Pennsylvania
1987-1994 Rhone-Poulenc Rorer
Collegeville, Pennsylvania
Cardiovascular Division Summer intern and part-time positions
1/2000-6/2000 Temple University Hospital
Department of Urology
8/2007-Present Sub-Investigator, Pfizer
12-WK, Randomized, Double-Blind, Placebo controlled, Parallel Group, Multicenter trial to Evaluate the Efficacy and Safety of a Fesoterodine Flexible Dose regimen in Patients with Overactive Bladder
6/2007-Present Sub-Investigator, Theralogix
A Randomized, Double-Blind, Placebo-
Controlled Trial of the Effect of a
Novel Nutritional Supplement on PSA
Kinetics in Men with Biochemical Recurrence
After Definitive therapy for Prostate Cancer.
5/2007-Present Sub-Investigator, Boston Scientific/Celsion
A 5-Year Trial for Post-Marketing Study Using Prolieve Microwave Therapy For The Treatment of Benign Prostatic Hyperplasia (BPH)
PROFESSIONAL ASSOCIATIONS:
1996-Present American Urological Association
2003-Present American Association of Clinical Urologists
2003-Present Baltimore County Medical Association
2004-Present Upper Chesapeake Medical Center CME committee
Hydrodistension increases inducible nitric oxide synthase in dog bladder mucosa. Society for Urodynamics & Female Urology. June 2001. Ruggieri Michael R., Braverman Alan S., Arrison Daniel P., Pontari Michel A.
Intravesical BCG and Alpha 2b interferon for superficial transitional cell carcinoma. Mid-Atlantic Section of the AUA. October 2001. Arrison Daniel P., Uzzo Robert G., Greenberg Richard E.